CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
NOV | Nephroblastoma overexpressed | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARHGAP36 | Rho GTPase activating protein 36 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PNMT | Phenylethanolamine N-methyltransferase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CHGB | Chromogranin B (secretogranin 1) | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
STAR | Steroidogenic acute regulatory protein | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
RAB3C | RAB3C, member RAS oncogene family | Predicted intracellular proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | Predicted intracellular proteins
| | | | | Group enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
RALYL | RALY RNA binding protein-like | Predicted intracellular proteins
| | | | | Group enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
NDRG4 | NDRG family member 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SCARB1 | Scavenger receptor class B, member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
PEG10 | Paternally expressed 10 | Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
CADPS | Ca++-dependent secretion activator | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DFNB31 | Deafness, autosomal recessive 31 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNAJC12 | DnaJ (Hsp40) homolog, subfamily C, member 12 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FDXR | Ferredoxin reductase | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HOXA5 | Homeobox A5 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KLHL4 | Kelch-like family member 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MYO7A | Myosin VIIA | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NGB | Neuroglobin | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | | | | Tissue enhanced |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PCSK2 | Proprotein convertase subtilisin/kexin type 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |